v3.26.1
Schedule of Investments (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Schedule of Investments [Line Items]    
Cost $ 122,573,899 [1],[2] $ 97,082,777 [3],[4]
Money market treasury fund 8,279,833 [1] 16,132,167 [3]
Money Market Funds At Fair Value $ 8,279,833 [1],[5] $ 16,132,167 [3],[6]
Money Market Funds Percent Of Net Assets 4.68% [1] 10.30% [3]
Investment Owned At Cost And Money Market Funds Carrying Value $ 130,853,732 [1] $ 113,214,944 [3]
Investment Owned At Fair Value And Money Market Funds Fair Value $ 165,915,379 [1],[5] $ 148,352,668 [3],[6]
Investment Owned And Money Market Funds Percent Of Net Assets 93.86% [1] 94.70% [3]
Fair Value $ 157,635,546 [1],[2],[5] $ 132,220,501 [3],[4],[6]
% of Net Assets 89.17% [1],[2] 84.40% [3],[4]
First American Treasury Obligations Fund [Member]    
Schedule of Investments [Line Items]    
Investment Yield Percentage 3.60% [1] 3.66% [3]
Money Market Funds Par Amount $ 8,279,833 [1],[7] $ 16,132,167 [3],[8]
Money market treasury fund 8,279,833 [1] 16,132,167 [3]
Money Market Funds At Fair Value 8,279,833 [1],[5] 16,132,167 [3],[6]
Non-controlled / non-affiliated equity investments [Member]    
Schedule of Investments [Line Items]    
Cost 73,020,469 [1] 67,734,047 [3]
Fair Value $ 88,012,712 [1],[5] $ 91,397,098 [3],[6]
% of Net Assets 49.79% [1] 58.34% [3]
Non-controlled / non-affiliated equity investments [Member] | Convertible Notes [Member]    
Schedule of Investments [Line Items]    
Cost $ 60,224,084 [1] $ 55,734,566 [3]
Fair Value $ 67,855,080 [1],[5] $ 70,841,757 [3],[6]
% of Net Assets 38.39% [1] 45.22% [3]
Non-controlled / non-affiliated equity investments [Member] | Equity Investments [Member]    
Schedule of Investments [Line Items]    
Cost $ 12,796,385 [1] $ 11,999,481 [3]
Fair Value $ 20,157,632 [1],[5] $ 20,555,341 [3],[6]
% of Net Assets 11.40% [1] 13.12% [3]
Non Controlled/Affiliated Investments [Member]    
Schedule of Investments [Line Items]    
Cost [1] $ 49,553,430  
Fair Value $ 69,622,834 [1],[5] $ 40,823,403
% of Net Assets [1] 39.39%  
Non Controlled/Affiliated Investments [Member] | Convertible Notes [Member]    
Schedule of Investments [Line Items]    
Cost [1] $ 5,000,000  
Fair Value [1],[5] $ 5,000,000  
% of Net Assets [1] 2.83%  
Non Controlled/Affiliated Investments [Member] | Equity Investments [Member]    
Schedule of Investments [Line Items]    
Cost $ 44,553,430 [1] 29,348,730 [3]
Fair Value $ 64,622,834 [1],[5] $ 40,823,403 [3],[6]
% of Net Assets 36.56% [1] 26.06% [3]
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Convertible Notes Healthcare Peregrine Health, Inc Type Unsecured Convertible Note Acquisition Date 3/19/2026 Interest Rate 10.0% Maturity Date 12/31/2027    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Mar. 19, 2026  
Interest Rate [1] 10.00%  
Maturity Date [1] Dec. 31, 2027  
Par Amount [1],[7] $ 3,000,000  
Cost [1] 3,000,000  
Fair Value [1],[5] $ 3,000,000  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series B-1 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Jun. 18, 2025  
Shares [1],[7],[10] 140,297  
Cost [1] $ 179,200  
Fair Value [1],[5] $ 320,837  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series B-2 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Jun. 18, 2025  
Shares [1],[7],[10] 219,309  
Cost [1] $ 280,121  
Fair Value [1],[5] $ 489,280  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series C-1 Preferred Stock Acquisition Date 8/11/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Aug. 11, 2025  
Shares [1],[7],[10] 848,677  
Cost [1] $ 1,942,197  
Fair Value [1],[5] $ 2,013,698  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series D Preferred Stock Acquisition Date 6/16/2026    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[10] Jun. 16, 2026  
Shares [1],[7],[10] 6,883,032  
Cost [1],[10] $ 16,001,604  
Fair Value [1],[5],[10] $ 18,928,534  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Seed 3 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[10] Jun. 18, 2025  
Shares [1],[7],[10] 640,168  
Cost [1],[10] $ 817,680  
Fair Value [1],[5],[10] $ 1,325,419  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Seed 3A Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[10] Jun. 18, 2025  
Shares [1],[7],[10] 1,212,073  
Cost [1],[10] $ 1,548,168  
Fair Value [1],[5],[10] $ 2,519,450  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Series Seed Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[10] Jun. 18, 2025  
Shares [1],[7],[10] 1,216,562  
Cost [1],[10] $ 1,553,902  
Fair Value [1],[5],[10] $ 2,484,105  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type eries Seed 4 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[10] Jun. 18, 2025  
Shares [1],[7],[10] 4,811,406  
Cost [1],[10] $ 6,145,558  
Fair Value [1],[5],[10] $ 10,119,940  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare Istios Health, LLC Type Series Seed Preferred Stock Acquisition Date 6/6/2025    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Jun. 06, 2025  
Shares [1],[7],[10] 4,000,000  
Cost [1] $ 4,000,000  
Fair Value [1],[5] $ 7,143,933  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare Korio, Inc. Type Series A Preferred Stock Acquisition Date 8/23/2024    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Aug. 23, 2024  
Shares [1],[7],[10] 11,848,341  
Cost [1] $ 3,500,000  
Fair Value [1],[5] $ 4,122,961  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Series A-2B Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Dec. 12, 2024  
Shares [1],[7],[10] 38,268,696  
Cost [1] $ 5,085,000  
Fair Value [1],[5] $ 8,447,028  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Series A-4 Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Dec. 12, 2024  
Shares [1],[7],[10] 21,848,748  
Cost [1] $ 2,876,666  
Fair Value [1],[5] $ 4,711,850  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Series A-4B Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Dec. 12, 2024  
Shares [1],[7],[10] 922,885  
Cost [1] $ 121,510  
Fair Value [1],[5] $ 199,069  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Warrants Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Dec. 12, 2024  
Shares [1],[7],[10] 22,771,633  
Cost [1] $ 501,824  
Fair Value [1],[5] $ 1,796,730  
Investment, Identifier [Axis]: Investments – non-controlled / affiliated Unsecured Convertible Notes Healthcare Korio, Inc. Type Unsecured Convertible Note Acquisition Date 2/13/2026 Interest Rate 10.0% Maturity Date 8/13/2027    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Feb. 13, 2026  
Interest Rate [1] 10.00%  
Maturity Date [1] Aug. 13, 2027  
Par Amount [1],[7] $ 2,000,000  
Cost [1] 2,000,000  
Fair Value [1],[5] $ 2,000,000  
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Convertible Notes Enterprise SaaS Mediafly, Inc. Type Senior Secured Convertible Note Acquisition Date 8/29/2023 Interest Rate 10.0% Maturity Date 2/27/2026    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9] Aug. 29, 2023  
Interest Rate [1] 10.00%  
Maturity Date [1],[11] Feb. 27, 2026  
Par Amount [1],[7] $ 48,500,000  
Cost [1] 48,500,000  
Fair Value [1],[5] $ 55,183,987  
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Convertible Notes Enterprise SaaS Mediafly, Inc. Type Senior Secured Convertible Note Acquisition Date 8/29/2023 Interest Rate 10.0% Maturity Date 3/1/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12]   Aug. 29, 2023
Interest Rate [3]   10.00%
Maturity Date [3]   Feb. 27, 2026
Par Amount [3],[7],[8]   $ 48,500,000
Cost [3]   48,500,000
Fair Value [3],[6]   $ 63,321,632
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Convertible Notes Healthcare PriorAuthNow, Inc. d/b/a Rhyme, Inc. Type Unsecured Convertible Note Acquisition Date 5/13/2026 Interest Rate 8.0% Maturity Date 5/1/2028    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[13] May 13, 2026  
Interest Rate [1],[13] 8.00%  
Maturity Date [1],[13] May 01, 2028  
Par Amount [1],[7],[13] $ 3,769,120  
Cost [1],[13] 3,769,120  
Fair Value [1],[5],[13] $ 3,769,120  
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Convertible Notes Technology-Enabled Marketplace CareSave Technologies, Inc. Type Junior Secured Convertible Note Acquisition Date 4/4/2025 Interest Rate 10.5% Maturity Date 3/31/2030    
Schedule of Investments [Line Items]    
Acquisition Date Apr. 04, 2025 [1],[9],[13] Apr. 04, 2025 [3],[12],[14]
Interest Rate 10.50% [1],[13] 10.50% [3],[14]
Maturity Date Mar. 31, 2030 [1],[13] Mar. 31, 2030 [3],[14]
Par Amount $ 2,986,370 [1],[7],[13] $ 2,984,566 [3],[8],[14]
Cost 2,986,370 [1],[13] 2,984,566 [3],[14]
Fair Value $ 2,986,370 [1],[5],[13] $ 2,984,566 [3],[6],[14]
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series B-1 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 18, 2025
Shares [3],[8],[15]   140,297
Cost [3],[15]   $ 179,200
Fair Value [3],[6],[15]   $ 355,602
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series B-2 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 18, 2025
Shares [3],[8],[15]   219,309
Cost [3],[15]   $ 280,121
Fair Value [3],[6],[15]   $ 541,607
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series C-1 Preferred Stock Acquisition Date 8/11/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Aug. 11, 2025
Shares [3],[8],[15]   848,677
Cost [3],[15]   $ 1,942,197
Fair Value [3],[6],[15]   $ 2,366,230
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Seed 3 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 18, 2025
Shares [3],[8],[15]   640,168
Cost [3],[15]   $ 817,680
Fair Value [3],[6],[15]   $ 1,399,217
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Seed 3A Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 18, 2025
Shares [3],[8],[15]   1,212,073
Cost [3],[15]   $ 1,548,168
Fair Value [3],[6],[15]   $ 2,652,529
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Seed 4 Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 18, 2025
Shares [3],[8],[15]   4,811,406
Cost [3],[15]   $ 6,145,558
Fair Value [3],[6],[15]   $ 10,569,762
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare ChartSpan Medical Technologies, Inc. Type Series Seed Preferred Stock Acquisition Date 6/18/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 18, 2025
Shares [3],[8],[15]   1,216,562
Cost [3],[15]   $ 1,553,902
Fair Value [3],[6],[15]   $ 2,648,146
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Integrative Life Network, LLC Type Class A Common Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date Dec. 12, 2024 [1],[9],[10] Dec. 12, 2024 [3],[12],[15]
Shares [3],[8],[15]   251,152
Cost [3],[15]   $ 522,718
Fair Value [3],[6],[15]   $ 224,275
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Integrative Life Network, LLC Type Class B Common Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date Dec. 12, 2024 [1],[9],[10] Dec. 12, 2024 [3],[12],[15]
Par Amount [1],[7],[10] $ 131,534  
Shares [3],[8],[15]   131,534
Cost 274,186 [1],[10] $ 274,186 [3],[15]
Fair Value 74,620 [1],[5],[10] $ 117,458 [3],[6],[15]
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Istios Health, LLC Type Series Seed Preferred Stock Acquisition Date 6/6/2025    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Jun. 06, 2025
Shares [3],[8],[15]   4,000,000
Cost [3],[15]   $ 4,000,000
Fair Value [3],[6],[15]   $ 4,000,000
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Korio, Inc. Type Series A Preferred Stock Acquisition Date 8/23/2024    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Aug. 23, 2024
Shares [3],[8],[15]   11,848,341
Cost [3],[15]   $ 3,500,000
Fair Value [3],[6],[15]   $ 3,777,486
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Series A-2B Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Dec. 12, 2024
Shares [3],[8],[15]   38,268,696
Cost [3],[15]   $ 5,085,000
Fair Value [3],[6],[15]   $ 6,936,063
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Series A-4 Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Dec. 12, 2024
Shares [3],[8],[15]   21,848,748
Cost [3],[15]   $ 2,876,666
Fair Value [3],[6],[15]   $ 3,856,738
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Series A-4B Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Dec. 12, 2024
Shares [3],[8],[15]   922,885
Cost [3],[15]   $ 121,510
Fair Value [3],[6],[15]   $ 162,947
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Healthcare Peregrine Health, Inc. Type Warrants Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Acquisition Date [3],[12],[15]   Dec. 12, 2024
Shares [3],[8],[15]   22,771,633
Cost [3],[15]   $ 501,824
Fair Value [3],[6],[15]   $ 1,215,343
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Technology-Enabled Marketplace CareSave Technologies, Inc. Type Series E-2 Preferred Stock Acquisition Date 12/12/2024    
Schedule of Investments [Line Items]    
Par Amount [1],[7],[10] 251,152  
Cost [1],[10] 522,718  
Fair Value [1],[5],[10] $ 142,480  
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Equity Investments Technology-Enabled Marketplace CareSave Technologies, Inc. Type Series E-2 Preferred Stock Acquisition Date 3/21/2024    
Schedule of Investments [Line Items]    
Acquisition Date Mar. 21, 2024 [1],[9],[10],[13] Mar. 21, 2024 [3],[12],[14],[15]
Par Amount [1],[7],[10],[13] $ 17,478  
Shares [3],[8],[14],[15]   17,478
Cost 11,999,481 [1],[10],[13] $ 11,999,481 [3],[14],[15]
Fair Value $ 19,940,532 [1],[5],[10],[13] $ 20,555,341 [3],[6],[14],[15]
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Unsecured Convertible Notes Healthcare Kythera Labs, Inc. Type Unsecured Convertible Note Acquisition Date 2/11/2025 Interest Rate 12.0% Maturity Date 10/1/2027    
Schedule of Investments [Line Items]    
Acquisition Date Feb. 11, 2025 [1],[9] Feb. 11, 2025 [3],[12]
Interest Rate 12.00% [1] 12.00% [3]
Maturity Date Oct. 01, 2027 [1] Oct. 01, 2027 [3]
Par Amount [7] $ 4,250,000 [1] $ 4,250,000 [3],[8]
Cost 4,250,000 [1] 4,250,000 [3]
Fair Value $ 5,197,009 [1],[5] $ 4,535,559 [3],[6]
Investment, Identifier [Axis]: Investments – non-controlled / non-affiliated Unsecured Convertible Notes Healthcare LynkCare, Inc. d/b/a OncoLens, Inc. Type Unsecured Convertible Note Acquisition Date 4/30/2026 Interest Rate 8.0% Maturity Date 7/30/2027    
Schedule of Investments [Line Items]    
Acquisition Date [1],[9],[13] Apr. 30, 2026  
Interest Rate [1],[13] 8.00%  
Maturity Date [1],[13] Jul. 30, 2027  
Par Amount [1],[7],[13] $ 718,594  
Cost [1],[13] 718,594  
Fair Value [1],[5],[13] $ 718,594  
[1] All investments are domiciled in the United States unless otherwise noted.
[2] Securities exempt from registration under the Securities Act (as defined in Note 1), and are deemed to be “restricted securities”. As of June 30, 2026, the aggregate fair value of these securities is $157.6 million or 89.2% of the Company’s net assets.
[3] All investments are domiciled in the United States unless otherwise noted.
[4] Securities exempt from registration under the Securities Act (as defined in Note 1), and are deemed to be “restricted securities”. As of December 31, 2025, the aggregate fair value of these securities is $132.2 million or 84.4% of the Company’s net assets.
[5] Unless otherwise indicated, these investments were valued using unobservable inputs and are considered Level 3 investments.
[6] Unless otherwise indicated, these investments were valued using unobservable inputs and are considered Level 3 investments.
[7] The total par amount is presented for convertible notes and the number of shares or units owned is presented for equity investments and cash equivalents.
[8] The total par amount is presented for convertible notes and the number of shares or units owned is presented for equity investments and cash equivalents.
[9] The initial acquisition dates have been included for the “restricted securities.”
[10] Equity investments are non-income-producing unless otherwise noted.
[11] The convertible notes had a stated maturity date of February 27, 2026. The Company has agreed to terms to extend the maturity date with Mediafly, Inc.; however, the extension has not been formally executed as of the reporting date.
[12] The initial acquisition dates have been included for the “restricted securities.”
[13] d/b/a is defined as “doing business as.”
[14] d/b/a is defined as “doing business as.”
[15] Equity investments are non-income-producing unless otherwise noted.